Cardina Health's trading volume on March 5th was $616 million, a 61.87% increase compared to the previous trading day.

On March 5, 2026, Cardinal Health (CAH), a health care products distributor company, had a trading value of $616 million, ranking 238th among U.S. stocks on that day. The trading value increased by 61.87% from the previous day, and the trading volume on the day was 2.8459 million shares.

Cardinal Health (CAH) fell 3.21% on March 5, 2026, to $216.02. The stock is down 4.89% over the past 5 trading days; down 5.76% for the entire month of March; up 5.12% since the beginning of the year; and up 69.53% over the past 52 weeks.

*If the company has been listed for less than 52 weeks, then the 52-week return is the return since listing (the same applies to cases where the listing period is less than 1 month or less than 5 trading days)

Cardinal Health (CAH) Trading value/US dollars Trading value change from yesterday Trading volume
March 5, 2026 $616 million 61.87% 2.8459 million
March 4, 2026 $381 million -29.49% 1.7017 million
March 3, 2026 $540 million 34.01% 2.3983 million
March 2, 2026 $403 million -14.84% 1.7511 million
February 27, 2026 $473 million 78.24% 2.0669 million

Cardinal Health released its 2026 fiscal year interim report on February 5, 2026. Revenue from July 1, 2025 to December 31, 2025 was $129.636 billion, up 20.55% year over year, and net profit was $925 million, up 13.08%.

Cardinal Health Group is an Ohio company founded in 1979. It is a globally integrated health care services and products company that provides customized solutions for hospitals, health systems, pharmacies, outpatient surgery centers, clinical laboratories, physician offices, and home patients. The company offers pharmaceuticals and medical products, as well as cost-effective solutions to improve supply chain efficiency. The company connects patients, providers, payers, pharmacists, and manufacturers to enable integrated care coordination and better patient management. The company manages its business and reports its financial performance, which is divided into two segments: pharmaceuticals and health care.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments